Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond.

Wong HL, Christie M, Gately L, Tie J, Lee B, Semira C, Lok SW, Wong R, Gibbs P.

Future Oncol. 2018 Jul 13. doi: 10.2217/fon-2018-0319. [Epub ahead of print]

PMID:
30004261
2.

[Diagnostic value of transient elastography for diagnosis of idiopathic non-cirrhotic portal hypertension].

He CY, Lyu Y, Chen H, Liu HB, Wang QH, Fan JH, Luo BH, Yu TL, Yuan XL, Tie J, Niu J, Guo WG, Yin ZX, Han GH.

Zhonghua Gan Zang Bing Za Zhi. 2018 Apr 20;26(4):310-312. doi: 10.3760/cma.j.issn.1007-3418.2018.04.015. Chinese. No abstract available.

PMID:
29996345
3.

Genotyping DNA isolated from UV irradiated human bloodstains using whole genome amplification.

Uchigasaki S, Tie J, Sobashima E, Shimada N.

Mol Biol Rep. 2018 Jul 7. doi: 10.1007/s11033-018-4240-6. [Epub ahead of print]

PMID:
29982892
4.

Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival.

Lee MM, MacKinlay A, Semira C, Schieber C, Jimeno Yepes AJ, Lee B, Wong R, Hettiarachchige CKH, Gunn N, Tie J, Wong HL, Skinner I, Jones IT, Keck J, Kosmider S, Tran B, Field K, Gibbs P.

Clin Colorectal Cancer. 2018 May 26. pii: S1533-0028(17)30436-X. doi: 10.1016/j.clcc.2018.05.008. [Epub ahead of print]

PMID:
29980491
5.

Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.

He C, Lv Y, Wang Z, Guo W, Tie J, Li K, Niu J, Zuo L, Yu T, Yuan X, Chen H, Wang Q, Liu H, Bai W, Wang E, Xia D, Luo B, Li X, Yuan J, Han N, Zhu Y, Wang J, Yin Z, Fan D, Han G.

Dig Liver Dis. 2018 Jun 5. pii: S1590-8658(18)30766-7. doi: 10.1016/j.dld.2018.05.022. [Epub ahead of print]

PMID:
29960900
6.

Re-inventing the randomized controlled trial in medical oncology: The registry-based trial.

Foroughi S, Wong HL, Gately L, Lee M, Simons K, Tie J, Burgess AW, Gibbs P.

Asia Pac J Clin Oncol. 2018 Jun 26. doi: 10.1111/ajco.12992. [Epub ahead of print] Review.

PMID:
29947051
7.

Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition.

Wu S, Chen X, Jin DY, Stafford DW, Pedersen LG, Tie JK.

Blood. 2018 May 9. pii: blood-2018-01-830901. doi: 10.1182/blood-2018-01-830901. [Epub ahead of print]

PMID:
29743176
8.

Compensation of Horizontal Gravity Disturbances for High Precision Inertial Navigation.

Tie J, Cao J, Wu M, Lian J, Cai S, Wang L.

Sensors (Basel). 2018 Mar 18;18(3). pii: E906. doi: 10.3390/s18030906.

9.

A Model of Gravity Vector Measurement Noise for Estimating Accelerometer Bias in Gravity Disturbance Compensation.

Tie J, Cao J, Chang L, Cai S, Wu M, Lian J.

Sensors (Basel). 2018 Mar 16;18(3). pii: E883. doi: 10.3390/s18030883.

10.

Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study.

Tie J, Cohen JD, Wang Y, Li L, Christie M, Simons K, Elsaleh H, Kosmider S, Wong R, Yip D, Lee M, Tran B, Rangiah D, Burge M, Goldstein D, Singh M, Skinner I, Faragher I, Croxford M, Bampton C, Haydon A, Jones IT, S Karapetis C, Price T, Schaefer MJ, Ptak J, Dobbyn L, Silliman N, Kinde I, Tomasetti C, Papadopoulos N, Kinzler K, Volgestein B, Gibbs P.

Gut. 2018 Feb 2. pii: gutjnl-2017-315852. doi: 10.1136/gutjnl-2017-315852. [Epub ahead of print]

PMID:
29420226
11.

Detection and localization of surgically resectable cancers with a multi-analyte blood test.

Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, Douville C, Javed AA, Wong F, Mattox A, Hruban RH, Wolfgang CL, Goggins MG, Dal Molin M, Wang TL, Roden R, Klein AP, Ptak J, Dobbyn L, Schaefer J, Silliman N, Popoli M, Vogelstein JT, Browne JD, Schoen RE, Brand RE, Tie J, Gibbs P, Wong HL, Mansfield AS, Jen J, Hanash SM, Falconi M, Allen PJ, Zhou S, Bettegowda C, Diaz LA Jr, Tomasetti C, Kinzler KW, Vogelstein B, Lennon AM, Papadopoulos N.

Science. 2018 Feb 23;359(6378):926-930. doi: 10.1126/science.aar3247. Epub 2018 Jan 18.

PMID:
29348365
12.

Emerging biomarkers for immunomodulatory cancer treatment of upper gastrointestinal, pancreatic and hepatic cancers.

Lee B, Hutchinson R, Wong HL, Tie J, Putoczki T, Tran B, Gibbs P, Christie M.

Semin Cancer Biol. 2017 Dec 16. pii: S1044-579X(17)30123-2. doi: 10.1016/j.semcancer.2017.12.009. [Epub ahead of print] Review.

PMID:
29258858
13.

Vitamin K epoxide reductase and its paralogous enzyme have different structures and functions.

Sinhadri BCS, Jin DY, Stafford DW, Tie JK.

Sci Rep. 2017 Dec 15;7(1):17632. doi: 10.1038/s41598-017-18008-3.

14.

Outcome of Hook Plate Fixation of Mallet Fractures.

Tie J, Hsieh MKH, Tay SC.

J Hand Surg Asian Pac Vol. 2017 Dec;22(4):416-422. doi: 10.1142/S0218810417500435.

PMID:
29117843
15.

Clinical guidance for radioiodine refractory differentiated thyroid cancer.

Gild ML, Topliss DJ, Learoyd D, Parnis F, Tie J, Hughes B, Walsh JP, McLeod DSA, Clifton-Bligh RJ, Robinson BG.

Clin Endocrinol (Oxf). 2018 Apr;88(4):529-537. doi: 10.1111/cen.13508. Epub 2017 Nov 24. Review.

PMID:
29095527
16.

Precision oncology using a clinician-directed, tailored approach to molecular profiling.

Lam M, Tran B, Beck S, Tie J, Herath D, Whittle J, Kwan EM, Fox SB, Fellowes A, Ananda S, Lipton L, Gibbs P, Rosenthal MA, Desai J.

Asia Pac J Clin Oncol. 2018 Feb;14(1):84-90. doi: 10.1111/ajco.12787. Epub 2017 Oct 30.

PMID:
29083093
17.

Surface micropattern reduces colonization and medical device-associated infections.

Xu B, Wei Q, Mettetal MR, Han J, Rau L, Tie J, May RM, Pathe ET, Reddy ST, Sullivan L, Parker AE, Maul DH, Brennan AB, Mann EE.

J Med Microbiol. 2017 Nov;66(11):1692-1698. doi: 10.1099/jmm.0.000600. Epub 2017 Oct 6.

18.

Study of the association between hemorrhage and the position of hemorrhagic stigmata in patients with esophageal varices.

Shen SH, Liu YD, Sun X, Li M, Sun GH, Wang J, Liu JT, Tie J, Yang J.

Exp Ther Med. 2017 Sep;14(3):2261-2264. doi: 10.3892/etm.2017.4727. Epub 2017 Jul 9.

19.

Circulating tumor DNA as a biomarker to guide therapy in post-operative locally advanced rectal cancer: the best option?

Tie J, Semira C, Gibbs P.

Expert Rev Mol Diagn. 2018 Jan;18(1):1-3. doi: 10.1080/14737159.2018.1386558. Epub 2017 Oct 6. No abstract available.

PMID:
28954554
20.

Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers.

Cohen JD, Javed AA, Thoburn C, Wong F, Tie J, Gibbs P, Schmidt CM, Yip-Schneider MT, Allen PJ, Schattner M, Brand RE, Singhi AD, Petersen GM, Hong SM, Kim SC, Falconi M, Doglioni C, Weiss MJ, Ahuja N, He J, Makary MA, Maitra A, Hanash SM, Dal Molin M, Wang Y, Li L, Ptak J, Dobbyn L, Schaefer J, Silliman N, Popoli M, Goggins MG, Hruban RH, Wolfgang CL, Klein AP, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Lennon AM.

Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10202-10207. doi: 10.1073/pnas.1704961114. Epub 2017 Sep 5.

21.

IL-17 contributes to the pathogenesis of obliterative bronchiolitis via regulation of M1 macrophages polarization in murine heterotopic trachea transplantation models.

Meng Q, Liu J, Lin F, Bao L, Jiang Y, Zheng L, Tie J, Zhang L, Liang X, Wei L, Li Y, Fan H, Zhou X.

Int Immunopharmacol. 2017 Nov;52:51-60. doi: 10.1016/j.intimp.2017.08.022. Epub 2017 Aug 31.

PMID:
28863322
22.

Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis.

Lv Y, He C, Wang Z, Guo W, Wang J, Bai W, Zhang L, Wang Q, Liu H, Luo B, Niu J, Li K, Tie J, Yin Z, Fan D, Han G.

Radiology. 2017 Dec;285(3):999-1010. doi: 10.1148/radiol.2017162266. Epub 2017 Jul 5.

PMID:
28682164
23.

Molecular basis of the first reported clinical case of congenital combined deficiency of coagulation factors.

Jin DY, Ingram BO, Stafford DW, Tie JK.

Blood. 2017 Aug 17;130(7):948-951. doi: 10.1182/blood-2017-05-782367. Epub 2017 Jul 5. No abstract available.

PMID:
28679738
24.

A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer.

Michael M, Bang YJ, Park YS, Kang YK, Kim TM, Hamid O, Thornton D, Tate SC, Raddad E, Tie J.

Target Oncol. 2017 Aug;12(4):463-474. doi: 10.1007/s11523-017-0502-9.

PMID:
28589492
25.

Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies.

Rohr UP, Herrmann P, Ilm K, Zhang H, Lohmann S, Reiser A, Muranyi A, Smith J, Burock S, Osterland M, Leith K, Singh S, Brunhoeber P, Bowermaster R, Tie J, Christie M, Wong HL, Waring P, Shanmugam K, Gibbs P, Stein U.

Ann Oncol. 2017 Aug 1;28(8):1869-1875. doi: 10.1093/annonc/mdx207.

PMID:
28460000
26.

miR-218 inhibited tumor angiogenesis by targeting ROBO1 in gastric cancer.

Zhang X, Dong J, He Y, Zhao M, Liu Z, Wang N, Jiang M, Zhang Z, Liu G, Liu H, Nie Y, Fan D, Tie J.

Gene. 2017 Jun 5;615:42-49. doi: 10.1016/j.gene.2017.03.022. Epub 2017 Mar 18.

PMID:
28323002
27.

How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia?

Au L, Turner N, Wong HL, Field K, Lee B, Boadle D, Cooray P, Karikios D, Kosmider S, Lipton L, Nott L, Parente P, Tie J, Tran B, Wong R, Yip D, Shapiro J, Gibbs P.

Asia Pac J Clin Oncol. 2018 Apr;14(2):e167-e174. doi: 10.1111/ajco.12671. Epub 2017 Mar 16.

PMID:
28299879
28.

Functional Study of the Vitamin K Cycle Enzymes in Live Cells.

Tie JK, Stafford DW.

Methods Enzymol. 2017;584:349-394. doi: 10.1016/bs.mie.2016.10.015. Epub 2016 Nov 22.

29.

The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort study.

Lee B, Wong HL, Tacey M, Tie J, Wong R, Lee M, Nott L, Shapiro J, Jennens R, Turner N, Tran B, Ananda S, Yip D, Richardson G, Parente P, Lim L, Stefanou G, Burge M, Iddawela M, Power J, Gibbs P.

Asia Pac J Clin Oncol. 2017 Aug;13(4):314-321. doi: 10.1111/ajco.12639. Epub 2016 Nov 25.

PMID:
27885818
30.

Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer.

Murphy C, Turner N, Wong HL, Sinnathamby M, Tie J, Lee B, Desai J, Skinner I, Christie M, Hutchinson R, Lunke S, Waring P, Gibbs P, Tran B.

Intern Med J. 2017 Jan;47(1):88-98. doi: 10.1111/imj.13312.

PMID:
27800646
31.

Splice-Site Mutation of Exon 3 Deletion in the Gamma-Glutamyl Carboxylase Gene Causes Inactivation of the Enzyme.

Jin DY, Vermeer C, Stafford DW, Tie JK.

J Invest Dermatol. 2016 Nov;136(11):2314-2317. doi: 10.1016/j.jid.2016.05.128. Epub 2016 Jul 6. No abstract available.

32.

Epigenetic roles in the malignant transformation of gastric mucosal cells.

Tie J, Zhang X, Fan D.

Cell Mol Life Sci. 2016 Dec;73(24):4599-4610. Epub 2016 Jul 27. Review.

33.

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.

Tie J, Wang Y, Tomasetti C, Li L, Springer S, Kinde I, Silliman N, Tacey M, Wong HL, Christie M, Kosmider S, Skinner I, Wong R, Steel M, Tran B, Desai J, Jones I, Haydon A, Hayes T, Price TJ, Strausberg RL, Diaz LA Jr, Papadopoulos N, Kinzler KW, Vogelstein B, Gibbs P.

Sci Transl Med. 2016 Jul 6;8(346):346ra92. doi: 10.1126/scitranslmed.aaf6219.

34.

Real-time PCR assay for the detection of picoplankton DNA distribution in the tissues of drowned rabbits.

Uchigasaki S, Tie J, Haseba T, Cui F, Ohno Y, Isobe E, Isahai I, Tsutsumi H.

Leg Med (Tokyo). 2016 May;20:33-6. doi: 10.1016/j.legalmed.2016.03.005. Epub 2016 Mar 11.

PMID:
27161920
35.

Sequencing Circulating Cell-Free DNA: The Potential to Refine Precision Cancer Medicine.

Tie J, Gibbs P.

Clin Chem. 2016 Jun;62(6):796-8. doi: 10.1373/clinchem.2015.253476. Epub 2016 Apr 26. No abstract available.

36.

Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer.

Ghosh P, Tie J, Muranyi A, Singh S, Brunhoeber P, Leith K, Bowermaster R, Liao Z, Zhu Y, LaFleur B, Tran B, Desai J, Jones I, Croxford M, Jover R, Goel A, Waring P, Hu S, Teichgraber V, Rohr UP, Ridder R, Shanmugam K, Gibbs P.

Clin Cancer Res. 2016 Jul 15;22(14):3488-98. doi: 10.1158/1078-0432.CCR-15-2290. Epub 2016 Mar 30.

37.

Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer.

Wong HL, Lee B, Field K, Lomax A, Tacey M, Shapiro J, McKendrick J, Zimet A, Yip D, Nott L, Jennens R, Richardson G, Tie J, Kosmider S, Parente P, Lim L, Cooray P, Tran B, Desai J, Wong R, Gibbs P.

Clin Colorectal Cancer. 2016 Jun;15(2):e9-e15. doi: 10.1016/j.clcc.2016.02.007. Epub 2016 Feb 13.

PMID:
26968236
38.

RAS Mutations as Predictive Biomarkers in Clinical Management of Metastatic Colorectal Cancer.

Waring P, Tie J, Maru D, Karapetis CS.

Clin Colorectal Cancer. 2016 Jun;15(2):95-103. doi: 10.1016/j.clcc.2015.10.006. Epub 2015 Nov 11. Review.

PMID:
26952655
39.

Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent.

Wong SF, Wong HL, Field KM, Kosmider S, Tie J, Wong R, Tacey M, Shapiro J, Nott L, Richardson G, Cooray P, Jones I, Croxford M, Gibbs P.

Clin Colorectal Cancer. 2016 Sep;15(3):e125-32. doi: 10.1016/j.clcc.2015.12.010. Epub 2015 Dec 29.

PMID:
26803709
40.

Characterization of vitamin K-dependent carboxylase mutations that cause bleeding and nonbleeding disorders.

Tie JK, Carneiro JD, Jin DY, Martinhago CD, Vermeer C, Stafford DW.

Blood. 2016 Apr 14;127(15):1847-55. doi: 10.1182/blood-2015-10-677633. Epub 2016 Jan 12.

41.

Structural and functional insights into enzymes of the vitamin K cycle.

Tie JK, Stafford DW.

J Thromb Haemost. 2016 Feb;14(2):236-47. doi: 10.1111/jth.13217. Epub 2016 Jan 29. Review.

42.

Survival impact of the Australian National Bowel Cancer Screening Programme.

Ananda S, Wong H, Faragher I, Jones IT, Steele M, Kosmider S, Desai J, Tie J, Field K, Wong R, Tran B, Bae S, Gibbs P.

Intern Med J. 2016 Feb;46(2):166-71. doi: 10.1111/imj.12916.

PMID:
26418334
43.

Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria.

Turner N, Wong HL, Templeton A, Tripathy S, Whiti Rogers T, Croxford M, Jones I, Sinnathamby M, Desai J, Tie J, Bae S, Christie M, Gibbs P, Tran B.

Int J Cancer. 2016 Feb 1;138(3):671-8. doi: 10.1002/ijc.29805. Epub 2015 Sep 2.

44.

Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer.

Karapetis CS, Maru D, Waring P, Tie J, Michael MZ.

Expert Rev Mol Diagn. 2015;15(8):1033-48. doi: 10.1586/14737159.2015.1052797. Epub 2015 Jul 12. Review.

PMID:
26166616
45.

Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients.

Bae S, Wong HL, Tie J, Desai J, Field K, Kosmider S, Fourlanos S, Jones I, Skinner I, Gibbs P.

J Cancer Epidemiol. 2015;2015:189132. doi: 10.1155/2015/189132. Epub 2015 May 5.

46.

POU2F2-oriented network promotes human gastric cancer metastasis.

Wang SM, Tie J, Wang WL, Hu SJ, Yin JP, Yi XF, Tian ZH, Zhang XY, Li MB, Li ZS, Nie YZ, Wu KC, Fan DM.

Gut. 2016 Sep;65(9):1427-38. doi: 10.1136/gutjnl-2014-308932. Epub 2015 May 27.

47.

Primary Tumor Resection in Patients With Metastatic Colorectal Cancer Is Associated With Reversal of Systemic Inflammation and Improved Survival.

Turner N, Tran B, Tran PV, Sinnathamby M, Wong HL, Jones I, Croxford M, Desai J, Tie J, Field KM, Kosmider S, Bae S, Gibbs P.

Clin Colorectal Cancer. 2015 Sep;14(3):185-91. doi: 10.1016/j.clcc.2015.02.004. Epub 2015 Mar 7.

PMID:
25882598
48.

Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in Australia.

Turner NH, Wong HL, Field K, Wong R, Shapiro J, Yip D, Nott L, Tie J, Kosmider S, Tran B, Desai J, McKendrick J, Zimet A, Richardson G, Iddawela M, Gibbs P.

Asia Pac J Clin Oncol. 2015 Sep;11(3):262-71. doi: 10.1111/ajco.12355. Epub 2015 Apr 14.

PMID:
25871458
49.

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer.

Tie J, Kinde I, Wang Y, Wong HL, Roebert J, Christie M, Tacey M, Wong R, Singh M, Karapetis CS, Desai J, Tran B, Strausberg RL, Diaz LA Jr, Papadopoulos N, Kinzler KW, Vogelstein B, Gibbs P.

Ann Oncol. 2015 Aug;26(8):1715-22. doi: 10.1093/annonc/mdv177. Epub 2015 Apr 7.

50.

Blood-based protein biomarker panel for the detection of colorectal cancer.

Fung KY, Tabor B, Buckley MJ, Priebe IK, Purins L, Pompeia C, Brierley GV, Lockett T, Gibbs P, Tie J, McMurrick P, Moore J, Ruszkiewicz A, Nice E, Adams TE, Burgess A, Cosgrove LJ.

PLoS One. 2015 Mar 20;10(3):e0120425. doi: 10.1371/journal.pone.0120425. eCollection 2015.

Supplemental Content

Support Center